Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Hayes

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 12, 2020
Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in ChildrenJoanne Kurtzberg, Susan Prockop, Sonali Chaudhury, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host DiseasePartow Kebriaei, Jack Hayes, Andrew Daly, et al.
Blood Advances|August 27, 2025
Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cellsMegan J Bywater, Rohit Haldar, Yashaswini Janardhanan, et al.
European Journal of Heart Failure|November 27, 2024
Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HFEmerson C Perin, Kenneth M Borow, Timothy D Henry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Hisham Abdel-Azim, Paul Carpenter, et al.
Emerging Infectious Diseases|January 21, 2003
Texas lifestyle limits transmission of dengue virusPaul Reiter, Sarah Lathrop, Michel Bunning, et al.
Bone Marrow Transplantation|September 2, 2021
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkersStelios Kasikis, Janna Baez, Isha Gandhi, et al.
Journal of the American College of Cardiology|March 1, 2023
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart FailureEmerson C Perin, Kenneth M Borow, Timothy D Henry, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2022
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 12, 2020
Study 275: Updated Expanded Access Program for Remestemcel-L in Steroid-Refractory Acute Graft-versus-Host Disease in ChildrenJoanne Kurtzberg, Susan Prockop, Sonali Chaudhury, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host DiseasePartow Kebriaei, Jack Hayes, Andrew Daly, et al.
Blood Advances|August 27, 2025
Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cellsMegan J Bywater, Rohit Haldar, Yashaswini Janardhanan, et al.
European Journal of Heart Failure|November 27, 2024
Mesenchymal precursor cells reduce mortality and major morbidity in ischaemic heart failure with inflammation: DREAM-HFEmerson C Perin, Kenneth M Borow, Timothy D Henry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 5, 2020
A Phase 3, Single-Arm, Prospective Study of Remestemcel-L, Ex Vivo Culture-Expanded Adult Human Mesenchymal Stromal Cells for the Treatment of Pediatric Patients Who Failed to Respond to Steroid Treatment for Acute Graft-versus-Host DiseaseJoanne Kurtzberg, Hisham Abdel-Azim, Paul Carpenter, et al.
Emerging Infectious Diseases|January 21, 2003
Texas lifestyle limits transmission of dengue virusPaul Reiter, Sarah Lathrop, Michel Bunning, et al.
Bone Marrow Transplantation|September 2, 2021
Mesenchymal stromal cell therapy induces high responses and survival in children with steroid refractory GVHD and poor risk biomarkersStelios Kasikis, Janna Baez, Isha Gandhi, et al.
Journal of the American College of Cardiology|March 1, 2023
Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart FailureEmerson C Perin, Kenneth M Borow, Timothy D Henry, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2022
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, et al.
Pageof 2